Literature DB >> 20978117

Making sense of missense in Lynch syndrome: the clinical perspective.

Henry T Lynch1, Thomas Jascur, Stephen Lanspa, C Richard Boland.   

Abstract

The DNA mismatch repair (MMR) system provides critical genetic housekeeping, and its failure is associated with tumorigenesis. Through distinct domains on the DNA MMR proteins, the system recognizes and repairs errors occurring during DNA synthesis, but signals apoptosis when the DNA damage cannot be repaired. Certain missense mutations in the MMR genes can selectively alter just one of these functions. This affects the clinical features of tumors associated with defective DNA MMR activity. New work reported by Xie et al. in this issue of the journal (beginning on page 1409) adds to the understanding of DNA MMR. ©2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20978117      PMCID: PMC2988077          DOI: 10.1158/1940-6207.CAPR-10-0204

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  28 in total

Review 1.  Microsatellite instability in colorectal cancer.

Authors:  C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

2.  An MLH1 mutation links BACH1/FANCJ to colon cancer, signaling, and insight toward directed therapy.

Authors:  Jenny Xie; Shawna Guillemette; Min Peng; Candace Gilbert; Andrew Buermeyer; Sharon B Cantor
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

3.  Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Authors:  Daniel J Sargent; Silvia Marsoni; Genevieve Monges; Stephen N Thibodeau; Roberto Labianca; Stanley R Hamilton; Amy J French; Brian Kabat; Nathan R Foster; Valter Torri; Christine Ribic; Axel Grothey; Malcolm Moore; Alberto Zaniboni; Jean-Francois Seitz; Frank Sinicrope; Steven Gallinger
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

4.  Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer.

Authors:  C Richard Boland; Moshe Shike
Journal:  Gastroenterology       Date:  2010-04-21       Impact factor: 22.682

5.  An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers.

Authors:  Ajay Goel; Takeshi Nagasaka; Richard Hamelin; C Richard Boland
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

6.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

Authors:  Marjolijn J L Ligtenberg; Roland P Kuiper; Tsun Leung Chan; Monique Goossens; Konnie M Hebeda; Marsha Voorendt; Tracy Y H Lee; Danielle Bodmer; Eveline Hoenselaar; Sandra J B Hendriks-Cornelissen; Wai Yin Tsui; Chi Kwan Kong; Han G Brunner; Ad Geurts van Kessel; Siu Tsan Yuen; J Han J M van Krieken; Suet Yi Leung; Nicoline Hoogerbrugge
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

Review 7.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.

Authors:  H T Lynch; P M Lynch; S J Lanspa; C L Snyder; J F Lynch; C R Boland
Journal:  Clin Genet       Date:  2009-07       Impact factor: 4.438

8.  Who should be sent for genetic testing in hereditary colorectal cancer syndromes?

Authors:  Henry T Lynch; C Richard Boland; Miguel A Rodriguez-Bigas; Christopher Amos; Jane F Lynch; Patrick M Lynch
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544

9.  A multidimensional analysis of genes mutated in breast and colorectal cancers.

Authors:  Jimmy Lin; Christine M Gan; Xiaosong Zhang; Siân Jones; Tobias Sjöblom; Laura D Wood; D Williams Parsons; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Giovanni Parmigiani; Victor E Velculescu
Journal:  Genome Res       Date:  2007-08-10       Impact factor: 9.043

Review 10.  EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.

Authors:  Glenn E Palomaki; Monica R McClain; Stephanie Melillo; Heather L Hampel; Stephen N Thibodeau
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

View more
  5 in total

Review 1.  Role of DNA repair defects in predicting immunotherapy response.

Authors:  Jing Zhang; David J H Shih; Shiaw-Yih Lin
Journal:  Biomark Res       Date:  2020-06-29

Review 2.  Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors.

Authors:  Sanjeevani Arora; Rodion Velichinskii; Randy W Lesh; Usman Ali; Michal Kubiak; Pranshu Bansal; Hossein Borghaei; Martin J Edelman; Yanis Boumber
Journal:  Adv Ther       Date:  2019-08-13       Impact factor: 3.845

Review 3.  Targeting DNA Repair Response Promotes Immunotherapy in Ovarian Cancer: Rationale and Clinical Application.

Authors:  Hongyu Xie; Wenjie Wang; Wencai Qi; Weilin Jin; Bairong Xia
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

Review 4.  Biomarkers of therapeutic response with immune checkpoint inhibitors.

Authors:  Poorva Bindal; Jhanelle E Gray; Theresa A Boyle; Vaia Florou; Sonam Puri
Journal:  Ann Transl Med       Date:  2021-06

5.  Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma.

Authors:  Lei Wu; Wen Quan; Qiong Luo; Ying Pan; Dongxu Peng; Guihai Zhang
Journal:  Front Mol Biosci       Date:  2020-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.